Relay Therapeutics
RLAY
RLAY
132 hedge funds and large institutions have $2.89B invested in Relay Therapeutics in 2021 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 55 increasing their positions, 29 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0.43% more ownership
Funds ownership: 98.58% → 99.01% (+0.43%)
11% less capital invested
Capital invested by funds: $3.26B → $2.89B (-$365M)
50% less funds holding in top 10
Funds holding in top 10: 8 → 4 (-4)
Holders
132
Holding in Top 10
4
Calls
$6.87M
Puts
$5.04M
Top Buyers
| 1 | +$105M | |
| 2 | +$35.2M | |
| 3 | +$25.6M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$18.6M |
| 5 |
State Street
Boston,
Massachusetts
|
+$14.6M |
Top Sellers
| 1 | -$97.8M | |
| 2 | -$28M | |
| 3 | -$20.4M | |
| 4 |
FCMV
Foresite Capital Management V
Larkspur,
California
|
-$14.6M |
| 5 |
O
OrbiMed
New York
|
-$12.8M |